MRNA earnings

Catalyst

MRNA earnings

MRNA earnings — 2026-07-31

Reported the quarter ending 2026-06-30: revenue $145M, diluted EPS -$1.97, net income -$782M (SEC filing). Across the print the stock moved -4.8% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

9 events
DateTypeEvent
Jul 31 UpdateAMGN — candidate.roundup Jul 31 ScanInsider Scan Jul 31 ScanHealthcare Scan Jul 31 ScanBiotech Scan Jul 28 UpdateAMGN — candidate.roundup Jul 28 ScanInsider Scan Jul 28 ScanHealthcare Scan Jul 28 ScanBiotech Scan Jul 25 UpdateTMO — candidate.roundup

No direct external sources are attached to this read.